semax and dihexa / / Selank Aerosol Spray · Disguised Alpha Semax | Neuroprotective Peptide |

Laboratory Safety Protocols Standard laboratory safety practices should always be followed when handling peptide reagents and other experimental compounds

Jun 07, 2026, 17:30 ET CagriSema, a once-weekly investigational treatment that combines a novel amylin analog with a GLP-1 receptor agonist (RA), achieved significant reductions in HbA 1c and bodyweight versus comparators across three phase 3 trials in adults with type 2 diabetes (T2D) 1-3 Data from the REIMAGINE clinical development program, a series of phase 3 trials evaluating once-weekly CagriSema in adults with T2D across various stages of their disease, were presented at an ADA symposium 1-3 Novo Nordisk continues to demonstrate pioneering leadership and scientific innovation through advancing diabetes research PLAINSBORO, N.J

Integration with medicine As evidence accumulates, mainstream medicine may increasingly incorporate peptide therapies

Sleep quality may improve